UK markets open in 6 hours 3 minutes

Almaden Minerals Ltd. (0UH8.L)

LSE - LSE Delayed price. Currency in CAD
Add to watchlist
0.2050+0.0200 (+10.81%)
At close: 03:01PM BST
Full screen
Previous close0.1850
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume10,000
Avg. volume290
Market cap281,303
Beta (5Y monthly)1.11
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Almaden Provides Corporate Update

    VANCOUVER, British Columbia, March 14, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) is providing an update regarding its Request for Consultations delivered to the United Mexican States (“Mexico”, see press release dated December 14, 2023), and its listing on the NYSE American stock exchange (see press release of October 25, 2023). Request for Consultations As previously reported, on December 13, 2023, Almaden delivered to Mexico a wri

  • GlobeNewswire

    Almaden requests consultations with Mexico under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership

    VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) announces that it has delivered to the United Mexican States (“Mexico”) a Request for Consultations in accordance with the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) relating to an investment dispute with Mexico. Almaden sent the Request for Consultations to Mexico’s General Directorate of Legal Consultancy for Intern

  • GlobeNewswire

    Almaden Announces Extension of Cure Period for NYSE American Listing

    VANCOUVER, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; NYSE American: AAU) announces that, further to its press release of April 21, 2023, it has received an extension of its cure deadline from October 19, 2023 to April 19, 2024 (“New Cure Deadline”). As previously announced, Almaden is not in compliance with the continued listing standards of the NYSE American exchange because the Company’s securities have been selling for a l